Maternal Transmission of a Humanised Igf2r Allele Results in an Igf2 Dependent Hypomorphic and Non-Viable Growth Phenotype

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Hughes, Jennifer ^a   Frago, Susana ^a   Bühnemann, Claudia ^a   Carter, Emma J ^a   Hassan, A Bassim ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SPLICING; EMBRYO; FEMALE; GENE TARGETING; GENOTYPE; GROWTH REGULATION; MALE; MOUSE; NONHUMAN; PHENOTYPE; PLACENTAL TRANSFER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANS SPLICING; TRANSGENE;

ANIMALS; FEMALE; GENOMIC IMPRINTING; INSULIN-LIKE GROWTH FACTOR II; MALE; MICE; PHENOTYPE; RECEPTORS, SOMATOMEDIN;

EID: 84874524232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057270     Document Type: Article

References (55)

1. Barlow DP, (2011) Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet 45: 379-403.
2. Ghosh P, Dahms NM, Kornfeld S, (2003) Mannose 6-phosphate receptors: new twists in the tale. Nat Rev Mol Cell Biol 4: 202-212.
3. Latos PA, Stricker SH, Steenpass L, Pauler FM, Huang R, et al. (2009) An in vitro ES cell imprinting model shows that imprinted expression of the Igf2r gene arises from an allele-specific expression bias. Development 136: 437-448.
4. Sleutels F, Zwart R, Barlow DP, (2002) The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 415: 810-813.
5. Stricker SH, Steenpass L, Pauler FM, Santoro F, Latos PA, et al. (2008) Silencing and transcriptional properties of the imprinted Airn ncRNA are independent of the endogenous promoter. EMBO J 27: 3116-3128.
6. Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, et al. (1997) Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 389: 745-749.
7. Wutz A, Theussl HC, Dausman J, Jaenisch R, Barlow DP, et al. (2001) Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. Development 128: 1881-1887.
8. Harper J, Burns JL, Foulstone EJ, Pignatelli M, Zaina S, et al. (2006) Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting. Cancer Res 66: 1940-1948.
9. Pravtcheva DD, Wise TL, (2008) Igf2r improves the survival and transmission ratio of Igf2 transgenic mice. Mol Reprod Dev 75: 1678-1687.
10. Zaina S, Newton RV, Paul MR, Graham CF, (1998) Local reduction of organ size in transgenic mice expressing a soluble insulin-like growth factor II/mannose-6-phosphate receptor. Endocrinology 139: 3886-3895.
11. Zaina S, Pettersson L, Ahren B, Branen L, Hassan AB, et al. (2002) Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 277: 4505-4511.
12. Lau MM, Stewart CE, Liu Z, Bhatt H, Rotwein P, et al. (1994) Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 8: 2953-2963.
13. Ludwig T, Eggenschwiler J, Fisher P, D'Ercole AJ, Davenport ML, et al. (1996) Mouse mutants lacking the type 2 IGF receptor (IGF2R) are rescued from perinatal lethality in Igf2 and Igf1r null backgrounds. Dev-Biol 177: 517-535 issn: 0012-1606.
14. Wang ZQ, Fung MR, Barlow DP, Wagner EF, (1994) Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372: 464-467.
15. Wylie AA, Pulford DJ, McVie-Wylie AJ, Waterland RA, Evans HK, et al. (2003) Tissue-specific inactivation of murine M6P/IGF2R. Am J Pathol 162: 321-328.
16. Haig D, Graham C, (1991) Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 64: 1045-1046.
17. Wilkins JF, Haig D, (2003) What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet 4: 359-368.
18. Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, et al. (2001) Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet 27: 153-154.
19. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM, (1995) Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375: 34-39.
20. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL, (1995) M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 11: 447-449.
21. De Souza AT, Yamada T, Mills JJ, Jirtle RL, (1997) Imprinted genes in liver carcinogenesis. FASEB J 11: 60-67.
22. Hankins GR, De Souza AT, Bentley RC, Patel MR, Marks JR, et al. (1996) M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Oncogene 12: 2003-2009.
23. Hoyo C, Murphy SK, Schildkraut JM, Vidal AC, Skaar D, et al. (2012) IGF2R genetic variants, circulating IGF2 concentrations and colon cancer risk in African Americans and Whites. Dis Markers 32: 133-141.
24. Killian JK, Oka Y, Jang HS, Fu X, Waterland RA, et al. (2001) Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Hum Mutat 18: 25-31.
25. Mills JJ, Falls JG, De Souza AT, Jirtle RL, (1998) Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene 16: 2797-2802.
26. Rezgui D, Williams C, Savage SA, Prince SN, Zaccheo OJ, et al. (2009) Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth. J Mol Endocrinol 42: 341-356.
27. Williams C, Hoppe HJ, Rezgui D, Strickland M, Forbes BE, et al. (2012) An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution. Science 338: 1209-1213.
28. DeChiara TM, Robertson EJ, Efstratiadis A, (1991) Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64: 849-859.
29. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4: 1265-1272.
30. Ahamed K, Epaud R, Holzenberger M, Bonora M, Flejou JF, et al. (2005) Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury. Respir Res 6: 31.
31. Rea S, Johnson TE, (2003) A metabolic model for life span determination in Caenorhabditis elegans. Dev Cell 5: 197-203.
32. Tu MP, Epstein D, Tatar M, (2002) The demography of slow aging in male and female Drosophila mutant for the insulin-receptor substrate homologue chico. Aging Cell 1: 75-80.
33. Bokov AF, Garg N, Ikeno Y, Thakur S, Musi N, et al. (2011) Does reduced IGF-1R signaling in Igf1r+/- mice alter aging? PLoS One 6: e26891.
34. Holzenberger M, Dupont J, Ducos B, Leneuve P, Geloen A, et al. (2003) IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187.
35. Jin C, Li J, Green CD, Yu X, Tang X, et al. (2011) Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab 14: 161-172.
36. Pehar M, O'Riordan KJ, Burns-Cusato M, Andrzejewski ME, del Alcazar CG, et al. (2010) Altered longevity-assurance activity of p53:p44 in the mouse causes memory loss, neurodegeneration and premature death. Aging Cell 9: 174-190.
37. Trotman LC, Niki M, Dotan ZA, Koutcher JA, Di Cristofano A, et al. (2003) Pten dose dictates cancer progression in the prostate. PLoS Biol 1: E59.
38. Alimonti A, Carracedo A, Clohessy JG, Trotman LC, Nardella C, et al. (2010) Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 42: 454-458.
39. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, et al. (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: 1033-1038.
40. Church DN, Phillips BR, Stuckey DJ, Barnes DJ, Buffa FM, et al. (2012) Igf2 ligand dependency of Pten(+/-) developmental and tumour phenotypes in the mouse. Oncogene 31: 3635-3646.
41. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, Eggan K, et al. (2002) Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 22: 2124-2135.
42. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492.
43. Linhart HG, Lin H, Yamada Y, Moran E, Steine EJ, et al. (2007) Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes Dev 21: 3110-3122.
44. Hagan JP, Kozlov SV, Chiang Y, Sewell L, Stewart CL, (2004) Intraspecific mating with CzechII/Ei mice rescue lethality associated with loss of function mutations of the imprinted genes, Igf2r and Cdkn1c. Genomics 84: 836-843.
45. Adkins RM, Somes G, Morrison JC, Hill JB, Watson EM, et al. (2010) Association of birth weight with polymorphisms in the IGF2, H19, and IGF2R genes. Pediatr Res 68: 429-434.
46. Biong M, Gram IT, Brill I, Johansen F, Solvang HK, et al. (2010) Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics 3: 9.
47. Cheng I, Stram DO, Burtt NP, Gianniny L, Garcia RR, et al. (2009) IGF2R missense single-nucleotide polymorphisms and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 18: 1922-1924.
48. Dong X, Li Y, Tang H, Chang P, Hess KR, et al. (2012) Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer. Cancer Epidemiol 36: 206-211.
49. Petry CJ, Ong KK, Wingate DL, Brown J, Scott CD, et al. (2005) Genetic variation in the type 2 insulin-like growth factor receptor gene and disparity in childhood height. Growth Horm IGF Res 15: 363-368.
50. Savage SA, Woodson K, Walk E, Modi W, Liao J, et al. (2007) Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 16: 1667-1674.
51. Burns JL, Hassan AB, (2001) Cell survival and proliferation are modified by insulin-like growth factor 2 between days 9 and 10 of mouse gestation. Development 128: 3819-3830.
52. DeChiara TM, Efstratiadis A, Robertson EJ, (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78-80.
53. Aricescu AR, Lu W, Jones EY, (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr 62: 1243-1250.
54. Shevchenko A, Wilm M, Vorm O, Mann M, (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858.
55. de Wet B, Zech T, Salek M, Acuto O, Harder T, (2011) Proteomic characterization of plasma membrane-proximal T cell activation responses. J Biol Chem 286: 4072-4080.